WA
GMED icon

WESPAC Advisors’s Globus Medical GMED Stock Holding History

WESPAC Advisors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$217K Buy
+2,746
New +$233K 0.11% 181

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

WESPAC Advisors's GMED Position: Q2 2026 in Review

WESPAC Advisors opened a new position in Globus Medical (GMED) in Q2 2026: 2,746 shares worth $217K. The stake represents 0.11% of the portfolio and ranks #181 among its holdings.

596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • WESPAC Advisors held 2,746 shares of Globus Medical worth $217K as of Q2 2026.
  • Globus Medical was a new WESPAC Advisors position in Q2 2026.
  • Globus Medical made up 0.11% of WESPAC Advisors's portfolio in Q2 2026, its #181 holding.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on WESPAC Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.